FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617402021> ?p ?o ?g. }

• W2617402021 endingPage "e000377" @default.
• W2617402021 startingPage "e000377" @default.
• W2617402021 abstract "<h3>Objective</h3> Treatment of type 1 diabetes has been intensified aiming at normalizing blood glucose, which may increase the risk of severe hypoglycemia (SH). We aimed to compare the incidence of SH events in the four Nordic countries Denmark, Iceland, Norway and Sweden, and to assess the influence of hemoglobin A1c (HbA_1c) and treatment modalities on the frequency of SH; particularly, to explore if a HbA_1c target ≤6.7% (50 mmol/mol) is feasible. <h3>Research design and methods</h3> Data on children below 15 years with a diabetes duration more than 1 year, registered in the national childhood diabetes databases in the four Nordic countries from 2008 to 2012, were compiled. Data completeness was more than 95%. <h3>Results</h3> Totally 8806 (48% females) patients with 29 715 person years were included, mean age and diabetes duration were 11 years and 5.1 years, respectively. The overall rate of SH was 6.0 per 100 patient-years, and did not change during the study period. The Swedish population constantly had the lowest SH incidence while it decreased significantly in the Danish population. HbA_1c decreased significantly over time (p<0.01), while the number of pump users increased (p<0.01). Stratifying for HbA_1c levels showed the lowest risk of SH in patients with HbA_1c ≤6.7% (≤50 mmol/mol), but in the statistical models adjusting for possible confounders the difference between the HbA_1c groups disappeared. Pump users had the lowest SH risk, also after adjusting for possible confounders. <h3>Conclusions</h3> Risk of SH differs between the Nordic countries with the lowest risk in Sweden. Pump therapy was associated with decreased risk of SH. The low HbA_1c group had the same or a lower risk of SH compared with the highest HbA_1c groups. A target HbA_1c ≤6.7% (≤50 mmol/mol) seems achievable without increasing the risk of SH." @default.
• W2617402021 created "2017-06-05" @default.
• W2617402021 creator A5003306663 @default.
• W2617402021 creator A5005096444 @default.
• W2617402021 creator A5015996564 @default.
• W2617402021 creator A5021689410 @default.
• W2617402021 creator A5026546706 @default.
• W2617402021 creator A5042351411 @default.
• W2617402021 creator A5042803610 @default.
• W2617402021 creator A5043068745 @default.
• W2617402021 creator A5056328871 @default.
• W2617402021 date "2017-05-01" @default.
• W2617402021 modified "2023-10-01" @default.
• W2617402021 title "Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A _{_1c} and treatment modality" @default.
• W2617402021 cites W1513128131 @default.
• W2617402021 cites W1908845299 @default.
• W2617402021 cites W1988519907 @default.
• W2617402021 cites W1994735607 @default.
• W2617402021 cites W1997771785 @default.
• W2617402021 cites W2007942949 @default.
• W2617402021 cites W2021934130 @default.
• W2617402021 cites W2031292911 @default.
• W2617402021 cites W2046721567 @default.
• W2617402021 cites W2061776732 @default.
• W2617402021 cites W2068170939 @default.
• W2617402021 cites W2079074987 @default.
• W2617402021 cites W2083980839 @default.
• W2617402021 cites W2102684459 @default.
• W2617402021 cites W2102877966 @default.
• W2617402021 cites W2126815788 @default.
• W2617402021 cites W2132151370 @default.
• W2617402021 cites W2139230122 @default.
• W2617402021 cites W2143546709 @default.
• W2617402021 cites W2145074254 @default.
• W2617402021 cites W2155698714 @default.
• W2617402021 cites W2163558382 @default.
• W2617402021 cites W2166103856 @default.
• W2617402021 cites W2405703114 @default.
• W2617402021 cites W2551570543 @default.
• W2617402021 cites W2769264260 @default.
• W2617402021 cites W2916931956 @default.
• W2617402021 cites W4241385086 @default.
• W2617402021 cites W4253299530 @default.
• W2617402021 doi "https://doi.org/10.1136/bmjdrc-2016-000377" @default.
• W2617402021 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5530237" @default.
• W2617402021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28761652" @default.
• W2617402021 hasPublicationYear "2017" @default.
• W2617402021 type Work @default.
• W2617402021 sameAs 2617402021 @default.
• W2617402021 citedByCount "37" @default.
• W2617402021 countsByYear W26174020212018 @default.
• W2617402021 countsByYear W26174020212019 @default.
• W2617402021 countsByYear W26174020212020 @default.
• W2617402021 countsByYear W26174020212021 @default.
• W2617402021 countsByYear W26174020212022 @default.
• W2617402021 countsByYear W26174020212023 @default.
• W2617402021 crossrefType "journal-article" @default.
• W2617402021 hasAuthorship W2617402021A5003306663 @default.
• W2617402021 hasAuthorship W2617402021A5005096444 @default.
• W2617402021 hasAuthorship W2617402021A5015996564 @default.
• W2617402021 hasAuthorship W2617402021A5021689410 @default.
• W2617402021 hasAuthorship W2617402021A5026546706 @default.
• W2617402021 hasAuthorship W2617402021A5042351411 @default.
• W2617402021 hasAuthorship W2617402021A5042803610 @default.
• W2617402021 hasAuthorship W2617402021A5043068745 @default.
• W2617402021 hasAuthorship W2617402021A5056328871 @default.
• W2617402021 hasBestOaLocation W26174020211 @default.
• W2617402021 hasConcept C120665830 @default.
• W2617402021 hasConcept C121332964 @default.
• W2617402021 hasConcept C126322002 @default.
• W2617402021 hasConcept C134018914 @default.
• W2617402021 hasConcept C138885662 @default.
• W2617402021 hasConcept C144024400 @default.
• W2617402021 hasConcept C149923435 @default.
• W2617402021 hasConcept C164622146 @default.
• W2617402021 hasConcept C187212893 @default.
• W2617402021 hasConcept C2777180221 @default.
• W2617402021 hasConcept C2778917026 @default.
• W2617402021 hasConcept C2780668416 @default.
• W2617402021 hasConcept C2781232474 @default.
• W2617402021 hasConcept C2908647359 @default.
• W2617402021 hasConcept C41895202 @default.
• W2617402021 hasConcept C555293320 @default.
• W2617402021 hasConcept C61511704 @default.
• W2617402021 hasConcept C71924100 @default.
• W2617402021 hasConcept C77350462 @default.
• W2617402021 hasConcept C99454951 @default.
• W2617402021 hasConceptScore W2617402021C120665830 @default.
• W2617402021 hasConceptScore W2617402021C121332964 @default.
• W2617402021 hasConceptScore W2617402021C126322002 @default.
• W2617402021 hasConceptScore W2617402021C134018914 @default.
• W2617402021 hasConceptScore W2617402021C138885662 @default.
• W2617402021 hasConceptScore W2617402021C144024400 @default.
• W2617402021 hasConceptScore W2617402021C149923435 @default.
• W2617402021 hasConceptScore W2617402021C164622146 @default.
• W2617402021 hasConceptScore W2617402021C187212893 @default.
• W2617402021 hasConceptScore W2617402021C2777180221 @default.
• W2617402021 hasConceptScore W2617402021C2778917026 @default.

• next